INTRODUCTION
Approximately one third of patients with chronic pancreatitis develop jaundice1. It may be due to hepatocellular disease or due to biliary obstruction. Abnormal liver function tests and transient rises in bilirubin are reasonably common during acute exacerbations of chronic pancreatitis2. In Bradley and Salam's large series of 868 patients, 125 (14070) had jaundice. In 29 of the 125 jaundiced patients (22070), the jaundice was due to extrahepatic obstruction. In only 13 patients (1.5070 of the total series) was obstruction due to benign pancreatic disease. In the other 16 patients the jaundice was secondary to gallstone disease3. In many patients stenosis of the intrapancreatic portion of the common bile duct is clinically silent3'4'5. In others there is an elevated alkaline phosphatase (S.A.P.) and this may be the earliest finding in 25678 patients with biliary obstruction
In patients with incomplete biliary obstruction biliary cirrhosis may supervene4'9. Lasting, clinically significant obstructive jaundice is much less common being seen in less than 47o of cases in most seriesl,3,0,11 Segal et al. 9 have described three clinical types of chronic pancreatitis with biliary obstruction transient, recurrent, and persistent. The present paper is concerned solely with clinically significant and lasting jaundice, not with the transient variety.
Obstructive jaundice may present as a progressive problem. Sarle et al. emphasised that anatomical changes in the common bile duct in patients with pancreatitis are common but symptoms are rare. Obstructive jaundice may present as a progressive problem developing against the background of known pancreatitis. At other times, it may present as relatively painless jaundice, making it difficult to distinguish from the jaundice caused by cancer.
Just as there may be confusion with cancer, so there may be confusion between the relative roles of chronic pancreatitis and biliary duct obstruction in causing pain. Recently, routine biliary bypass has been advocated as part of a conservative surgical program designed to preserve pancreatic function12. The results of such methods of treatment are not yet documented.
Finally, there is uncertainty about the factors which contribute to the development of jaundice, and there is no clear patient profile which may alert a clinician to anticipate incipient jaundice or to diagnose pancreatitis when the jaundice is established.
MATERIALS AND METHODS
Patients presenting with proven chronic pancreatitis to one surgical unit between 1979 and 1986 have been included. All patients have been followed for at least two years in order to exclude as far as possible those with undiagnosed malignancy. Only patients with clinically significant and progressive obstructive jaundice caused by pancreatic pathology and present for more than one week have been included. Diagnosis of chronic pancreatitis was confirmed at autopsy in one patient. The remainder were required to satisfy at least two of the following criteria: a typical history of upper abdominal pain; documented rises in serum amylase; calcification in the pancreas demonstrated on conventional radiology or computerised tomography; an endoscopic retrograde cholangiopancreaticogram (ERCP) demonstrating ductal irregularity and filling of the secondary ducts, dilatation of pancreatic ducts or pancreatic calculi; and biopsy or cytological absence of malignancy. Patients with jaundice caused by gallstones were excluded from the study. All patients have been personally followed by one of the authors (JML).
Data has been gathered prospectively and maintained on a computerised database. Statistics were calculated using a Stats plus programme. Non-parametric analysis was used and Fisher's exact test chosen to test the significance of results except where the expected frequency was more than 5 in which case Chi-squared analysis was chosen.
RESULTS

General
Eleven patients of 57 with proven chronic pancreatitis presented with clinically significant obstructive jaundice lasting more than one week. Seven of the 11 were male, compared to 35 of the remaining 46 patients. The median age of the jaundiced patients was 44 years (range 22-69 years). The median age of "the 46 non-jaundiced patients was also 44 years (range 15 to 74 years). Three of the 11 patients presented as jaundice of unknown cause. The remaining 8 were known to have chronic pancreatitis before their jaundice developed. Specific details of liver function and of common bile duct dilatation have been listed in Table 1 .
The median duration of symptoms from onset of pain to onset of jaundice was 7 
Malabsorption
Three of the 11 jaundiced patients had malabsorption at the time of presentation with their jaundice that required permanent supplementation with pancreatic enzyme preparations. Only 2 of the remaining 46 patients had malabsorption requiring treatment. This difference is of marginal statistical significance (Fisher exact probability p= .045).
Surgical Treatment
One patient required no surgical treatment, his jaundice subsiding spontaneously at two weeks. In the remaining 10, the gallbladder was used as a bypass conduit 5 times, and the common hepatic duct 4 times. One patient had a transduodenal sphincterotomy.
The pancreatic pain was independantly treated in 5 patients, 3 times by pancreaticojejunostomy, once by sphincteroplasty and once by total pancreatectomy.
Hospital Mortality
There was only one hospital death (within 30 days of surgery or before discharge from hospital at any time). This death occured in a jaundiced patient, who developed haemorrhigic pancreatitis as a complication of his chronic relapsing pancreatitis of alcoholic origin.
Pain relief
At the time of writing, 9 of the 10 surviving patients from the jaundiced group were pain free or reported significant improvement in their pain. This compares with 24 of 46 patients improved in the non-jaundiced group. This difference is statistically significant (Fisher exact test p= .028).
DISCUSSION
It is important to recognise that the patients discussed in this paper had proven chronic pancreatitis. Those with obstructive jaundice caused by stones have been excluded, and indeed there was a notable absence of chronic biliary pancreatitis in the jaundiced group. Each patient had clinically significant jaundice that persisted for longer than a week, and all had evidence of duct obstruction with appropriate liver function tests and dilated ducts demonstrated by ultrasound and/or computerised tomography (CT) scanning.
When obstructive jaundice is defined in this fashion, the crude incidence in the 57 patients studied was 19%. This figure is higher than that reported in other series 1'3''1. The cumulative frequency, as determined by life table analysis, reached 347o by the end of the 10th year from the onset of symptoms (Figure 1 ). Although the numbers are far too small to generalise, the risk seems to diminish at about that time, and none of the 10 patients with symptoms persisting for longer than 10 years have developed obstructive jaundice. Obstructive jaundice was most commonly seen in those patients with known chronic pancreatitis, and 8 of the 11 in this small study had known chronic pancreatitis for a median of 7 years before jaundice developed. This represents 8 cases occuring in 54 patients with previously known pancreatitis, an incidence of 1570 at a median follow-up time of 5 years.
Less commonly, patients presented with obstructive jaundice of unknown cause, and were found to have chronic pancreatitis. This represents a relatively rare syndrome, which was noted only three times in 113 patients presenting with obstructive jaundice as their primary problem during the same period.
There is some evidence from this study and others 12'14 that the disease is more "destructive" in the patients who become jaundiced. There was a higher incidence of diabetes, of glandular calcification and of clinically significant malabsorption amongst the jaundiced patients. Calcification was also very common in the patients described by other authors1'5'15.
From a clinical point of view, distinction of chronic pancreatitis from cancer is all important8''15'6. The earliest surgical literature on this subject emphasises this problem7'8'19'2. Even after extensive investigation, up to 10070 of patients may prove to have unexpected cancers 1'15. The diagnosis of cancer is particularly important in an era when stenting is frequently employed as a method of palliative treatment for malignant jaundice21'22. We have found preoperative and intraoperative cytology of particular value in diagnosing carcinoma. The degree of confidence with which cytology can rule out carcinoma is not yet known. While the specificity of cytological examination for pancreatic cancer approaches 100070, the number of false negative cases is yet to be ascertained accurately, but appears to be about 20070 23, 24, 25 Such negative or equivocal results continue to be a problem. We are at present following four patients with negative or equivocal cytology in whom we did not feel that radical resection could be justified since no diagnosis of malignancy could be proven. None of these patients complained of pain.
Only one of the 11 jaundiced patients in this series required no surgical treatment.
A number of operations can be used including sphincteroplasty, choledochoduodenostomy, choledochojejunostomy, and cholecystojejunostomy. Littenberg 13 has emphasised that the technical factors are an important consideration in the choice of operation. A small common bile duct represents one potential hazard26. Sphincteroplasty should only be used if the stricture is short8. Some authors have suggested that utilizing the gallbladder as a form of drainage conduit is associated with an unsatisfactory incidence of cholangitis and the unpredictability of the long term patency of the cystic duct11'13'27'28. Bradley and Salam3, have advocated choledochoduodenostomy because bile is not diverted away from the duodenum, because future pancreatic surgery is not compromised and because stricture from this anastomosis is uncommon. In our experience it seems that the gallbladder works perfectly well as a drainage conduit, as does the common hepatic duct. Pancreatitis must be treated on its merits, and according to the size of the pancreatic duct. Stenting is not favoured because of the common occurrence of cholangitis and stent blockage 21'22 as well as the theoretical risk of provoking acute pancreatitis from partial pancreatic duct obstruction.
The outcome of treatment in these 11 patients has been remarkably good. Nine of the 10 surviving patients have remained free of jaundice and with their pain improved. One death occured in an alcoholic with an acute exacerbation of chronic pancreatitis. He died as a result of multi-organ failure after a leak developed at the site of his cholecystojejunal anastomosis. Warshaw et al. found similarly pleasing results following surgical intervention and suggested that the patient's pain in this particular subset of patients was due to biliary as distinct from pancreatic obstruction. Other authors3'5'29'3'3, however, found that pain was not improved after biliary bypass. Since the minimum time of follow-up in this series of patients has been two years, we would suggest that the improvement in pain is probably clinically significant32. It is important that both physicians and surgeons dealing with pancreatitis and dealing with obstructive jaundice remain aware of the association between the two conditions. Jaundice due to biliary obstruction by benign pancreatic pathology is easily overlooked but remains a remediable cause of symptoms and complications in patients with chronic pancreatitis. It is also important to realise that clinical jaundice due to chronic pancreatitis can present as relatively painless jaundice, although it is more common to see jaundice in a patient with long-standing chronic pancreatitis. Stenting should probably be avoided in such patients. The general prognosis seems to be good for jaundice, for pain and for life. Chronic pancreatitis may constitute yet another "malignant masquerade ''33 in jaundiced patients.
